TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Fractyl Health, Inc. ( (GUTS) ).
On October 3, 2025, Fractyl Health, Inc. held a Special Meeting of Stockholders where 64.12% of the company’s common stock voting power was represented. During the meeting, stockholders approved the issuance of shares in accordance with Nasdaq rules related to a financing transaction and also approved the potential adjournment of the meeting to solicit additional proxies if necessary.
The most recent analyst rating on (GUTS) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Fractyl Health, Inc. stock, see the GUTS Stock Forecast page.
Spark’s Take on GUTS Stock
According to Spark, TipRanks’ AI Analyst, GUTS is a Neutral.
Fractyl Health’s overall stock score is primarily impacted by its precarious financial performance, characterized by high leverage and negative cash flows. While there is some positive momentum in technical indicators and cautious optimism from the earnings call, the company’s valuation remains weak due to a lack of profitability. The stock’s future performance is heavily reliant on upcoming data readouts and strategic initiatives.
To see Spark’s full report on GUTS stock, click here.
More about Fractyl Health, Inc.
Average Trading Volume: 2,539,681
Technical Sentiment Signal: Sell
Current Market Cap: $194.3M
For detailed information about GUTS stock, go to TipRanks’ Stock Analysis page.